National Status: Improving
Most Recent Data:
0.40
deaths with hepatitis B as the underlying or contributing cause of death per 100,000 population
(2024) *
National Target:
0.16
per 100,000 1
*
Desired Direction:
Decrease desired
National Baseline:
0.46 deaths with hepatitis B as the underlying or contributing cause of death per 100,000 population were reported in 2017 *
* Age adjusted to the year 2000 standard population.
View CI in the chart by hovering over a data point.
View SE in the chart by hovering over a data point.
Confidence Interval (CI) not available Standard Error (SE) not available Confidence Interval (CI) and Standard Error (SE) are not available
Deaths with hepatitis B as the underlying or contributing cause, 2017-2024 *
(deaths with hepatitis B as the underlying or contributing cause of death per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Total |
0.46 CI 0.44 / 0.49 SE 0.012 |
0.43 CI 0.41 / 0.45 SE 0.011 |
0.42 CI 0.40 / 0.44 SE 0.011 |
0.45 CI 0.43 / 0.47 SE 0.011 |
0.44 CI 0.42 / 0.46 SE 0.011 |
0.43 CI 0.41 / 0.45 SE 0.010 |
0.43 CI 0.41 / 0.45 SE 0.011 |
0.40 CI 0.38 / 0.42 SE 0.010 |
Deaths with hepatitis B as the underlying or contributing cause by Sex, 2017-2024 *
(deaths with hepatitis B as the underlying or contributing cause of death per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Male |
0.70 CI 0.66 / 0.74 SE 0.020 |
0.65 CI 0.62 / 0.69 SE 0.019 |
0.66 CI 0.62 / 0.70 SE 0.019 |
0.66 CI 0.63 / 0.70 SE 0.019 |
0.65 CI 0.61 / 0.68 SE 0.019 |
0.65 CI 0.62 / 0.69 SE 0.019 |
0.65 CI 0.61 / 0.68 SE 0.019 |
0.60 CI 0.57 / 0.64 SE 0.018 |
Female |
0.23 CI 0.20 / 0.25 SE 0.011 |
0.22 CI 0.20 / 0.24 SE 0.011 |
0.21 CI 0.19 / 0.24 SE 0.011 |
0.22 CI 0.20 / 0.24 SE 0.011 |
0.22 CI 0.20 / 0.25 SE 0.011 |
0.22 CI 0.20 / 0.24 SE 0.010 |
0.22 CI 0.20 / 0.25 SE 0.011 |
0.21 CI 0.19 / 0.24 SE 0.010 |
Deaths with hepatitis B as the underlying or contributing cause by Race/Ethnicity, 2017-2024 *
(deaths with hepatitis B as the underlying or contributing cause of death per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
American Indian or Alaska Native only |
DNA |
DSU |
0.52 CI 0.30 / 0.85 SE 0.127 |
0.38 CI 0.21 / 0.65 SE 0.098 |
0.43 CI 0.26 / 0.71 SE 0.101 |
0.42 CI 0.25 / 0.69 SE 0.101 |
0.46 CI 0.27 / 0.74 SE 0.107 |
DSU |
Asian only |
DNA |
2.10 CI 1.90 / 2.32 SE 0.104 |
2.11 CI 1.91 / 2.32 SE 0.101 |
2.44 CI 2.23 / 2.66 SE 0.109 |
2.41 CI 2.21 / 2.63 SE 0.106 |
2.09 CI 1.90 / 2.29 SE 0.096 |
2.03 CI 1.85 / 2.23 SE 0.094 |
1.81 CI 1.65 / 1.99 SE 0.085 |
Native Hawaiian or Other Pacific Islander only |
DNA |
2.58 CI 1.51 / 4.31 SE 0.623 |
2.41 CI 1.41 / 4.02 SE 0.583 |
3.01 CI 1.89 / 4.69 SE 0.638 |
4.77 CI 3.32 / 6.76 SE 0.809 |
3.98 CI 2.69 / 5.77 SE 0.722 |
3.15 CI 2.04 / 4.74 SE 0.625 |
3.06 CI 2.00 / 4.56 SE 0.596 |
Black or African American only |
DNA |
0.70 CI 0.63 / 0.79 SE 0.041 |
0.63 CI 0.56 / 0.71 SE 0.038 |
0.69 CI 0.62 / 0.78 SE 0.040 |
0.66 CI 0.59 / 0.75 SE 0.039 |
0.69 CI 0.61 / 0.77 SE 0.039 |
0.68 CI 0.61 / 0.76 SE 0.038 |
0.66 CI 0.58 / 0.73 SE 0.037 |
White only |
DNA |
0.27 CI 0.25 / 0.29 SE 0.010 |
0.28 CI 0.26 / 0.30 SE 0.010 |
0.28 CI 0.26 / 0.30 SE 0.010 |
0.26 CI 0.24 / 0.27 SE 0.009 |
0.28 CI 0.26 / 0.29 SE 0.010 |
0.27 CI 0.25 / 0.29 SE 0.009 |
0.23 CI 0.22 / 0.25 SE 0.009 |
2 or more races |
DNA |
0.31 CI 0.16 / 0.55 SE 0.087 |
0.31 CI 0.17 / 0.53 SE 0.082 |
0.22 CI 0.11 / 0.41 SE 0.064 |
0.28 CI 0.16 / 0.47 SE 0.071 |
0.26 CI 0.14 / 0.45 SE 0.069 |
0.37 CI 0.23 / 0.58 SE 0.083 |
0.24 CI 0.13 / 0.40 SE 0.061 |
Hispanic or Latino |
DNA |
0.28 CI 0.23 / 0.34 SE 0.027 |
0.27 CI 0.22 / 0.32 SE 0.026 |
0.28 CI 0.23 / 0.33 SE 0.025 |
0.28 CI 0.23 / 0.33 SE 0.025 |
0.29 CI 0.24 / 0.34 SE 0.025 |
0.26 CI 0.22 / 0.31 SE 0.023 |
0.24 CI 0.20 / 0.29 SE 0.022 |
Not Hispanic or Latino |
DNA |
0.44 CI 0.42 / 0.46 SE 0.012 |
0.44 CI 0.42 / 0.46 SE 0.012 |
0.46 CI 0.44 / 0.49 SE 0.012 |
0.45 CI 0.43 / 0.47 SE 0.012 |
0.46 CI 0.44 / 0.48 SE 0.012 |
0.45 CI 0.43 / 0.47 SE 0.012 |
0.42 CI 0.40 / 0.44 SE 0.011 |
American Indian or Alaska Native only, not Hispanic or Latino |
DNA |
DSU |
0.69 CI 0.38 / 1.15 SE 0.177 |
0.59 CI 0.33 / 0.99 SE 0.152 |
0.57 CI 0.32 / 0.96 SE 0.147 |
0.60 CI 0.35 / 1.01 SE 0.150 |
0.72 CI 0.42 / 1.17 SE 0.173 |
DSU |
Asian only, not Hispanic or Latino |
DNA |
2.13 CI 1.92 / 2.35 SE 0.106 |
2.12 CI 1.92 / 2.33 SE 0.102 |
2.48 CI 2.27 / 2.71 SE 0.111 |
2.43 CI 2.23 / 2.66 SE 0.107 |
2.12 CI 1.93 / 2.32 SE 0.098 |
2.06 CI 1.88 / 2.26 SE 0.095 |
1.83 CI 1.66 / 2.01 SE 0.086 |
Native Hawaiian or Other Pacific Islander only, not Hispanic or Latino |
DNA |
3.10 CI 1.79 / 5.20 SE 0.767 |
3.03 CI 1.77 / 5.00 SE 0.728 |
3.89 CI 2.45 / 6.00 SE 0.821 |
5.95 CI 4.13 / 8.42 SE 1.015 |
5.01 CI 3.40 / 7.21 SE 0.903 |
4.09 CI 2.66 / 6.10 SE 0.810 |
3.97 CI 2.60 / 5.87 SE 0.772 |
Black or African American only, not Hispanic or Latino |
DNA |
0.72 CI 0.64 / 0.81 SE 0.042 |
0.67 CI 0.59 / 0.75 SE 0.040 |
0.69 CI 0.61 / 0.77 SE 0.040 |
0.66 CI 0.59 / 0.75 SE 0.039 |
0.70 CI 0.62 / 0.78 SE 0.040 |
0.69 CI 0.62 / 0.78 SE 0.040 |
0.68 CI 0.60 / 0.76 SE 0.039 |
White only, not Hispanic or Latino |
DNA |
0.27 CI 0.25 / 0.29 SE 0.010 |
0.28 CI 0.26 / 0.30 SE 0.011 |
0.27 CI 0.25 / 0.29 SE 0.011 |
0.26 CI 0.24 / 0.28 SE 0.010 |
0.28 CI 0.25 / 0.30 SE 0.011 |
0.26 CI 0.24 / 0.28 SE 0.010 |
0.25 CI 0.23 / 0.27 SE 0.010 |
2 or more races, not Hispanic or Latino |
DNA |
0.33 CI 0.16 / 0.60 SE 0.098 |
0.37 CI 0.21 / 0.65 SE 0.099 |
0.28 CI 0.15 / 0.52 SE 0.083 |
0.31 CI 0.17 / 0.54 SE 0.084 |
0.27 CI 0.14 / 0.49 SE 0.079 |
0.45 CI 0.27 / 0.71 SE 0.102 |
0.30 CI 0.17 / 0.50 SE 0.076 |
Deaths with hepatitis B as the underlying or contributing cause by Age group, 2017-2024 †
(deaths with hepatitis B as the underlying or contributing cause of death per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
<18 years |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
0-4 years |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
5-11 years |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
12-17 years |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
18-44 years |
0.11 CI 0.10 / 0.14 SE 0.010 |
0.13 CI 0.11 / 0.15 SE 0.011 |
0.13 CI 0.11 / 0.15 SE 0.011 |
0.12 CI 0.10 / 0.14 SE 0.010 |
0.13 CI 0.11 / 0.15 SE 0.010 |
0.11 CI 0.09 / 0.13 SE 0.009 |
0.13 CI 0.11 / 0.15 SE 0.010 |
0.11 CI 0.10 / 0.13 SE 0.010 |
18-24 years |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
25-44 years |
0.16 CI 0.13 / 0.18 SE 0.013 |
0.18 CI 0.15 / 0.21 SE 0.014 |
0.17 CI 0.15 / 0.20 SE 0.014 |
0.16 CI 0.13 / 0.19 SE 0.013 |
0.17 CI 0.14 / 0.20 SE 0.014 |
0.14 CI 0.11 / 0.16 SE 0.012 |
0.17 CI 0.15 / 0.20 SE 0.014 |
0.15 CI 0.13 / 0.18 SE 0.013 |
45-64 years |
1.03 CI 0.96 / 1.10 SE 0.035 |
0.96 CI 0.89 / 1.03 SE 0.034 |
0.91 CI 0.84 / 0.98 SE 0.033 |
0.91 CI 0.84 / 0.98 SE 0.033 |
0.90 CI 0.84 / 0.97 SE 0.033 |
0.92 CI 0.85 / 0.99 SE 0.033 |
0.87 CI 0.81 / 0.94 SE 0.033 |
0.77 CI 0.71 / 0.83 SE 0.031 |
45-54 years |
0.76 CI 0.68 / 0.85 SE 0.042 |
0.68 CI 0.60 / 0.76 SE 0.040 |
0.62 CI 0.55 / 0.71 SE 0.039 |
0.67 CI 0.59 / 0.75 SE 0.041 |
0.65 CI 0.58 / 0.73 SE 0.040 |
0.63 CI 0.56 / 0.72 SE 0.040 |
0.61 CI 0.54 / 0.69 SE 0.039 |
0.56 CI 0.49 / 0.64 SE 0.037 |
55-64 years |
1.30 CI 1.20 / 1.42 SE 0.056 |
1.23 CI 1.13 / 1.34 SE 0.054 |
1.18 CI 1.08 / 1.29 SE 0.053 |
1.14 CI 1.04 / 1.25 SE 0.052 |
1.14 CI 1.04 / 1.24 SE 0.052 |
1.19 CI 1.09 / 1.30 SE 0.053 |
1.12 CI 1.02 / 1.23 SE 0.052 |
0.97 CI 0.88 / 1.07 SE 0.048 |
65 years and over |
1.42 CI 1.31 / 1.52 SE 0.053 |
1.32 CI 1.22 / 1.42 SE 0.050 |
1.39 CI 1.29 / 1.49 SE 0.051 |
1.54 CI 1.43 / 1.64 SE 0.053 |
1.51 CI 1.41 / 1.62 SE 0.052 |
1.57 CI 1.47 / 1.68 SE 0.052 |
1.50 CI 1.41 / 1.61 SE 0.050 |
1.44 CI 1.35 / 1.54 SE 0.049 |
65-74 years |
1.40 CI 1.27 / 1.55 SE 0.069 |
1.38 CI 1.26 / 1.52 SE 0.067 |
1.54 CI 1.40 / 1.68 SE 0.070 |
1.52 CI 1.39 / 1.66 SE 0.068 |
1.52 CI 1.39 / 1.66 SE 0.067 |
1.59 CI 1.45 / 1.73 SE 0.069 |
1.53 CI 1.40 / 1.66 SE 0.066 |
1.39 CI 1.27 / 1.51 SE 0.063 |
75-84 years |
1.48 CI 1.29 / 1.69 SE 0.100 |
1.30 CI 1.13 / 1.49 SE 0.092 |
1.22 CI 1.06 / 1.40 SE 0.087 |
1.57 CI 1.38 / 1.77 SE 0.098 |
1.42 CI 1.24 / 1.61 SE 0.094 |
1.55 CI 1.37 / 1.74 SE 0.094 |
1.42 CI 1.25 / 1.60 SE 0.088 |
1.36 CI 1.20 / 1.54 SE 0.084 |
85 years and over |
1.33 CI 1.06 / 1.64 SE 0.143 |
1.07 CI 0.83 / 1.35 SE 0.128 |
1.07 CI 0.84 / 1.36 SE 0.128 |
1.53 CI 1.25 / 1.86 SE 0.152 |
1.69 CI 1.38 / 2.05 SE 0.168 |
1.57 CI 1.28 / 1.91 SE 0.156 |
1.63 CI 1.33 / 1.98 SE 0.162 |
1.97 CI 1.65 / 2.35 SE 0.175 |
Deaths with hepatitis B as the underlying or contributing cause by Educational attainment (25-64 years), 2017-2024 *
(deaths with hepatitis B as the underlying or contributing cause of death per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Educational attainment (25-64 years) |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
Deaths with hepatitis B as the underlying or contributing cause by Family income, 2017-2024 *
(deaths with hepatitis B as the underlying or contributing cause of death per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Family income |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Deaths with hepatitis B as the underlying or contributing cause by Health insurance status, 2017-2024 *
(deaths with hepatitis B as the underlying or contributing cause of death per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Health insurance status |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Deaths with hepatitis B as the underlying or contributing cause by Geographic location, 2017-2024 * 2
(deaths with hepatitis B as the underlying or contributing cause of death per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Metropolitan |
0.47 CI 0.44 / 0.49 SE 0.012 |
0.46 CI 0.43 / 0.48 SE 0.012 |
0.42 CI 0.40 / 0.44 SE 0.011 |
0.44 CI 0.42 / 0.46 SE 0.011 |
0.45 CI 0.42 / 0.47 SE 0.012 |
DNA |
DNA |
DNA |
Non-metropolitan |
0.37 CI 0.32 / 0.43 SE 0.027 |
0.38 CI 0.32 / 0.44 SE 0.029 |
0.40 CI 0.35 / 0.47 SE 0.030 |
0.36 CI 0.31 / 0.42 SE 0.027 |
0.39 CI 0.34 / 0.45 SE 0.028 |
DNA |
DNA |
DNA |
Deaths with hepatitis B as the underlying or contributing cause by Marital status (25 years and over), 2017-2024 *
(deaths with hepatitis B as the underlying or contributing cause of death per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Marital status (25 years and over) |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
Deaths with hepatitis B as the underlying or contributing cause by Country of birth, 2017-2024 *
(deaths with hepatitis B as the underlying or contributing cause of death per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Country of birth |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
Deaths with hepatitis B as the underlying or contributing cause by Veteran status, 2017-2024 *
(deaths with hepatitis B as the underlying or contributing cause of death per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Veteran status |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Deaths with hepatitis B as the underlying or contributing cause by Disability status, 2017-2024 *
(deaths with hepatitis B as the underlying or contributing cause of death per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Disability status |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Deaths with hepatitis B as the underlying or contributing cause by Sexual orientation, 2017-2024 *
(deaths with hepatitis B as the underlying or contributing cause of death per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Sexual orientation |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Deaths with hepatitis B as the underlying or contributing cause by Gender identity, 2017-2024 *
(deaths with hepatitis B as the underlying or contributing cause of death per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Gender identity |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |